论文部分内容阅读
目的:探析采用不同治疗方案治疗剖宫产术后子宫瘢痕妊娠(CSP)的临床疗效。方法:随机选取我院2011年8月--2013年6月收治的36例剖宫产术后子宫瘢痕妊娠患者,并按照患者接受治疗的意愿将其分为两组。其中,采用药物预处理+宫腔镜下胚胎组织清除术进行治疗的患者为A组(20例),采用子宫动脉栓塞+宫腔镜下胚胎组织清除术进行治疗的患者为B组(16例)。治疗结束后,比较两组患者的手术情况、治疗的成功率以及住院时间等。结果:A组患者的术中出血量、手术时间、膨宫液葡萄糖用量及吸收量均明显少于B组患者(P<0.05)。两组患者术后血β-hCG恢复时间和月经恢复时间的差异无统计学意义(P>0.05)。A组患者阴道流血的时间和住院时间均明显短于B组患者(P<0.05)。两组患者治疗成功率间的差异无统计学意义(P>0.05)。结论:药物预处理+宫腔镜下胚胎组织清除术和子宫动脉栓塞+宫腔镜下胚胎组织清除术均为治疗剖宫产术后子宫瘢痕妊娠的有效方法,但前者对患者造成的损伤更小、临床使用的范围更广泛。
Objective: To investigate the clinical efficacy of different treatment regimens in treating uterine scar pregnancy (CSP) after cesarean section. Methods: Thirty - six patients with uterine scar pregnancy after cesarean section were randomly selected in our hospital from August 2011 to June 2013 and divided into two groups according to their willingness to receive treatment. Among them, patients treated with drug pretreatment + hysterosalotomy were group A (n = 20), patients treated with uterine artery embolization + hysteroscopic embryo excision were group B (n = 16) ). After treatment, the operation conditions, treatment success rate and hospital stay of the two groups were compared. Results: The blood loss, operation time, glucose dosage and absorption of group A were significantly less than those of group B (P <0.05). The postoperative blood β-hCG recovery time and menstruation recovery time had no significant difference between the two groups (P> 0.05). The time of vaginal bleeding and hospital stay in group A were significantly shorter than those in group B (P <0.05). The difference between the two groups in the treatment success rate was not statistically significant (P> 0.05). Conclusion: Pretreatment + hysterosalotomy and uterine artery embolization + hysteroscopic embryo tissue removal are all effective methods for the treatment of uterine scar pregnancy after cesarean section, but the injury to the former is more Small, clinical use of a wider range.